Online citations, reference lists, and bibliographies.

Extrapleural Pneumonectomy Is The Preferred Surgical Management In The Multimodality Therapy Of Pleural Mesothelioma: Con Argument

R. Cameron
Published 2006 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant pleural mesothelioma (MPM) is an uncommon asbestos-related cancer with few good treatment options. Due to its low incidence/prevalence, frequent delay in diagnosis, and a strikingly short survival, few patients generally have been available for clinical trials. Because of a lack of therapeutic options, MPM historically has received little attention in many comprehensive cancer centers across the U.S. and throughout the world. In treatment centers that have specific programs for mesothelioma, treatment strategies often are remarkably different and based on considerable treatment biases. Recently, one of the surgical strategies that some centers have adopted is that of extrapleural pneumonectomy (EPP). Although the use of EPP in this disease has been enthusiastically embraced at a number of centers, it is superiority over a meticulous and complete radical pleurectomy and decortication (P/D) and even over non-operative treatment essentially remains unproven. In order to optimally and scientifically assess the place of EPP in the treatment armamentarium of MPM, this paper will review the theoretical and reported advantages of EPP compared to a lung-sparing approach such as P/D.
This paper references
10.1016/J.LUNGCAN.2004.11.003
Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary.
D. Maziak (2005)
10.1016/S1010-7940(96)01008-1
Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.
O. Soysal (1997)
10.1007/BF02306613
Surgically debulked malignant pleural mesothelioma: Results and prognostic factors
H. Pass (2006)
10.1378/chest.32.3.340
Malignant mesothelioma of the pleura.
A. Tramujas (1957)
10.1016/S1010-7940(02)00273-7
The management of malignant pleural mesothelioma; single centre experience in 10 years.
T. Aziz (2002)
10.1016/S0003-4975(99)01038-3
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.
V. Rusch (1999)
10.1007/S002680020021
Treatment of Malignant Mesothelioma
M. Jaklitsch (2001)
10.1016/J.LUNGCAN.2005.03.032
Consensus report: pretreatment minimal staging and treatment of potentially resectable malignant pleural mesothelioma.
J. Van Meerbeeck (2005)
10.1067/MTC.2001.116560
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
10.1016/J.JTCVS.2004.02.021
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.
D. Sugarbaker (2004)
10.1016/S1010-7940(01)00594-2
Trimodality management of malignant pleural mesothelioma.
G. Maggi (2001)
10.1016/S0025-6196(12)65411-1
Malignant mesothelioma of the pleura.
R. J. Pisani (1988)
10.1002/(SICI)1097-0142(19981115)83:10<2099::AID-CNCR8>3.0.CO;2-3
Intrapleural administration of interleukin‐2 for the treatment of patients with malignant pleural mesothelioma
P. Astoul (1998)
10.1378/chest.108.3.754
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.
C. Boutin (1995)
10.1067/MTC.2002.125817
Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
T. T. Lee (2002)



This paper is referenced by
10.1097/01.COT.0000383778.58160.53
Speak Up: Reflections from a Nightmare Patient – Me!
Andrew Lawson (2010)
10.2995/JACSURG.25.687
胸膜中皮腫の外科治療を巡る諸問題 : EPPかP/Dか
坪田 紀明 (2011)
10.1265/JJH.66.558
[Current status and future direction of Japan's clinical trial for malignant pleural mesothelioma].
S. Hasegawa (2011)
10.1080/17476348.2019.1679119
Types of surgery post-neoadjuvant chemotherapy for pleural mesothelioma
Kozo Kuribayashi (2019)
Body composition analysis in the assessment of cancer cachexia treatment outcomes.
A. Aslani (2008)
10.1093/ejcts/ezr192
Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.
A. Nakas (2012)
10.1016/j.jtcvs.2015.10.036
Pleurectomy decortication for mesothelioma: The procedure of choice when possible.
R. Flores (2016)
10.1097/JTO.0b013e31824ab6c5
Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural Mesothelioma
L. Lang-Lazdunski (2012)
10.1007/s00595-015-1275-3
Current surgical strategies for malignant pleural mesothelioma
T. Takuwa (2015)
10.1016/j.lungcan.2014.01.021
Surgery for malignant pleural mesothelioma: why, when and what?
Loic Lang-Lazdunski (2014)
10.13032/TJOP.2052-5931.100120
The Role of Surgery in Malignant Pleural Mesothelioma
Levon Toufektzian (2015)
10.1016/j.athoracsur.2018.07.081
Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma?
S. Kim (2019)
10.1586/17476348.2016.1171147
The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence
P. Bertoglio (2016)
10.1007/s11748-007-0243-2
Malignant mesothelioma: current status and perspective in Japan and the world
S. Hasegawa (2008)
10.1007/s11748-019-01064-z
Return to work after surgical treatment for malignant pleural mesothelioma: report of a case
M. Takenaka (2019)
10.1007/s11748-014-0389-7
Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma
S. Hasegawa (2014)
Semantic Scholar Logo Some data provided by SemanticScholar